Product Code: ETC343731 | Publication Date: Aug 2022 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Algeria quinine market is experiencing growth driven by the rising prevalence of malaria and the increasing demand for antimalarial drugs. Quinine, known for its effectiveness in treating malaria, remains a crucial component in the healthcare system of Algeria. With the government`s efforts to combat malaria and improve healthcare infrastructure, the demand for quinine and other antimalarial medications is expected to remain robust in the foreseeable future.
In Algeria, the quinine market is experiencing notable growth, driven by several key factors. Firstly, the increasing prevalence of malaria and other vector-borne diseases in the region is boosting the demand for quinine-based medications. Quinine, known for its antimalarial properties, remains a crucial component in the treatment of malaria, especially in areas where the disease is endemic. Additionally, the use of quinine in the treatment of nocturnal leg cramps is contributing to market growth, as the condition is relatively common among the population. Furthermore, the pharmaceutical industry`s focus on developing novel formulations and dosage forms of quinine to enhance efficacy and patient compliance is driving market expansion in Algeria. Despite the availability of alternative antimalarial drugs, quinine continues to play a significant role in combating malaria, sustaining its demand in the Algeria market.
In Algeria quinine market, regulatory hurdles and compliance issues pose significant challenges for manufacturers and distributors. Quality control measures and adherence to international standards are essential but may require substantial investments in testing facilities and certifications. Furthermore, fluctuations in raw material prices and supply chain disruptions impact the production and availability of quinine-based products, affecting market stability.
Given the pharmaceutical applications of quinine, government policies in Algeria focus on ensuring the availability, quality, and affordability of essential medicines. Regulatory frameworks govern the production, importation, and distribution of quinine-based medications to safeguard public health and promote access to treatment. Additionally, policies may support domestic pharmaceutical manufacturing capabilities and research initiatives aimed at developing innovative quinine-based therapies.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Algeria Quinine Market Overview |
3.1 Algeria Country Macro Economic Indicators |
3.2 Algeria Quinine Market Revenues & Volume, 2021 & 2031F |
3.3 Algeria Quinine Market - Industry Life Cycle |
3.4 Algeria Quinine Market - Porter's Five Forces |
3.5 Algeria Quinine Market Revenues & Volume Share, By Mode of Administration, 2021 & 2031F |
3.6 Algeria Quinine Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Algeria Quinine Market Revenues & Volume Share, By End-user, 2021 & 2031F |
4 Algeria Quinine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of malaria in Algeria |
4.2.2 Growing awareness about the benefits of quinine in treating malaria |
4.2.3 Government initiatives to improve healthcare infrastructure and access to essential medicines |
4.3 Market Restraints |
4.3.1 Stringent regulations and quality standards for pharmaceutical products in Algeria |
4.3.2 Competition from alternative anti-malarial drugs in the market |
5 Algeria Quinine Market Trends |
6 Algeria Quinine Market, By Types |
6.1 Algeria Quinine Market, By Mode of Administration |
6.1.1 Overview and Analysis |
6.1.2 Algeria Quinine Market Revenues & Volume, By Mode of Administration, 2021-2031F |
6.1.3 Algeria Quinine Market Revenues & Volume, By Oral Administration, 2021-2031F |
6.1.4 Algeria Quinine Market Revenues & Volume, By Intravenous Administration, 2021-2031F |
6.1.5 Algeria Quinine Market Revenues & Volume, By Intramuscular Administration, 2021-2031F |
6.1.6 Algeria Quinine Market Revenues & Volume, By Others, 2021-2031F |
6.2 Algeria Quinine Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Algeria Quinine Market Revenues & Volume, By Antimalarial, 2021-2031F |
6.2.3 Algeria Quinine Market Revenues & Volume, By Antipyretic, 2021-2031F |
6.2.4 Algeria Quinine Market Revenues & Volume, By Others, 2021-2031F |
6.3 Algeria Quinine Market, By End-user |
6.3.1 Overview and Analysis |
6.3.2 Algeria Quinine Market Revenues & Volume, By Hospitals, 2021-2031F |
6.3.3 Algeria Quinine Market Revenues & Volume, By Clinics, 2021-2031F |
6.3.4 Algeria Quinine Market Revenues & Volume, By Ambulatory Surgical Centers, 2021-2031F |
6.3.5 Algeria Quinine Market Revenues & Volume, By Others, 2021-2031F |
7 Algeria Quinine Market Import-Export Trade Statistics |
7.1 Algeria Quinine Market Export to Major Countries |
7.2 Algeria Quinine Market Imports from Major Countries |
8 Algeria Quinine Market Key Performance Indicators |
8.1 Number of reported malaria cases in Algeria |
8.2 Government expenditure on healthcare infrastructure |
8.3 Number of healthcare facilities stocking quinine |
8.4 Percentage of healthcare professionals recommending quinine for malaria treatment |
9 Algeria Quinine Market - Opportunity Assessment |
9.1 Algeria Quinine Market Opportunity Assessment, By Mode of Administration, 2021 & 2031F |
9.2 Algeria Quinine Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Algeria Quinine Market Opportunity Assessment, By End-user, 2021 & 2031F |
10 Algeria Quinine Market - Competitive Landscape |
10.1 Algeria Quinine Market Revenue Share, By Companies, 2024 |
10.2 Algeria Quinine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |